Max Healthcare Institute Ltd (MAXHEALTH)
₹860.00
Mkt cap
₹83,705 Cr
P/E ratio
58.90
P/B
7.41
Div yield
0.23%
ROE
14.70%
ROCE
14.70%
EPS (TTM)
₹14.60
Book value
₹116
52W range
797–1,214
Sector
Healthcare
Price history
Previous close
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
NSE MAXHEALTHBSE 543220
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthHigh
TechnicalsBearish
52-week range
−29.14% from high₹860
₹797+7.90% from low₹1,214
Current
₹860.00
Prev close
₹851.15
Day
+1.04%
Price performance
1D
+1.04%
1W
+5.52%
1M
−12.43%
3M
−23.54%
6M
−14.56%
1Y
−28.98%
YTD
−19.07%
Financials
Revenue, profit & margin
P/E ratio
58.9×
MAXHEALTH is 33% above the sector median of 44.4×
MAXHEALTH58.9×
Sector median44.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,363 | 1,335 | 1,423 | 1,543 | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 | 2,569 | |
| Expenses | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 | 1,858 | |
| Operating Profit | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 | 711 | |
| OPM % | 28% | 29% | 27% | 25% | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% | 28% | |
| Other Income | 45 | 46 | 45 | 35 | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 | 41 | |
| Interest | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 | 74 | |
| Depreciation | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 | 138 | |
| Profit before tax | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 | 541 | |
| Tax % | 24% | 20% | 25% | 26% | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% | 23% | |
| Net Profit | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 | 414 | |
| EPS in Rs | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.09 | 3.52 | 3.31 | 4.26 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.29% · closed higher next day 15 of last 24
| Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 31 Jan '24 | 22 May '24◦ | 1 Aug '24 | 5 Nov '24◦ | 30 Jan '25 | 20 May '25◦ | 13 Aug '25 | 14 Nov '25◦ | 5 Feb '26 | 21 May '26◦ | 13 Aug '26 | 30 Oct '26 |
| Earnings day | +6.03% | −4.20% | +0.19% | +3.38% | +1.84% | −1.94% | +0.52% | +1.68% | +1.50% | −6.22% | +0.58% | — |
| +1 day | +9.06% | −5.83% | −0.65% | +3.27% | +3.54% | −1.42% | −3.17% | +1.23% | +1.40% | −8.27% | +0.11% | — |
| +5 days | +13.03% | −6.87% | −5.13% | −4.09% | +14.12% | −1.35% | −0.83% | +4.78% | +3.65% | −13.99% | −0.95% | — |
| +15 days | +15.98% | +6.17% | −7.51% | −6.21% | −0.54% | +1.92% | −7.19% | −2.15% | +8.24% | −5.70% | −1.25% | — |
| +30 days | −0.55% | +9.01% | −1.55% | +11.55% | −3.35% | +10.31% | −10.88% | −5.65% | −5.91% | +2.50% | +0.65% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Dividend - Rs 2 Per Share | 2.00 | 3 Jul '26 | 3 Jul '26 |
Shareholding
as of Sep 202623.71%Promoter
Promoters23.71%
FIIs40.52%1.26
DIIs31.01%1.06
Public4.76%0.21
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports7
Concall transcripts77
PPTOct 2026TranscriptAug 2026PPTAug 2026RECAug 2026PPTAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026PPTFeb 2026RECFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025PPTAug 2025TranscriptMay 2025
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Oct - Newspaper Publication pertaining to Financial Results for the quarter and half year ended September 30, 2026Announcement under Regulation 30 (LODR)-Change in Management 30 Oct - Board approved Q2 FY27 results, ₹93 Cr Noida and ₹97 Cr Vaishali expansion capex, and ₹1,143 Cr Gurugram project revision.Presentation On Earnings Update 30 Oct - Q2 FY27 revenue rose 20% to ₹3,219 Cr; PAT ₹448 Cr; ₹415 Cr capex approved for 209 beds.Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Oct - Q2 FY27 revenue rose 20% to ₹3,219 Cr; PAT up 10%, ₹415 Cr capex approved, Dwarka oncology block started.Board Meeting Outcome for Meeting Held On October 30, 2026 30 Oct - Board approved Q2 FY27 results, ₹93 crore Noida capex, ₹97 crore Vaishali capex, and ₹1,143 crore Gurugram project revision.